InFocus Therapeutics

Specializing in the discovery of new drug candidates using its in silico drug design technology platforms, InFocus is developing a pipeline of small molecules capable of modulating the translation of oncogenic mRNAs. Its drug candidates, with excellent brain penetration properties, target central nervous system cancers such as glioblastoma and brain metastases, opening up new prospects for treating previously inaccessible targets.